Guided pelvic resections in tumor surgery


Guided Pelvic Resections in Tumor Surgery, Alexander, John, H.; Mayerson, Joel, L.; Scharschmidt, Thomas, J. Techniques in Orthopaedics (Publish Ahead of Print)


Primary bone sarcoma of the pelvis is one of the more challenging pathologies treated by orthopedic oncologists. In particular, their anatomic complexity contributes to delays in diagnosis and high rates of positive margins with associated high rates of local recurrence, all contributing to poor outcomes in this patient population. Computer-assisted surgery in the form of navigation and patient-specific instrumentation has shown promise in other fields of orthopedics. Intuitively, in an effort to improve tumor resections and improve oncologic outcomes, surgeons have been working to apply these advances to orthopedic oncology. Early studies have demonstrated benefits from guided pelvic resections, with studies demonstrating improved resection accuracy, fewer positive margins and decreased rates of local recurrence. Although these techniques are promising and will likely become an essential tool for orthopedic oncologist, surgeons must understand the limitations and costs associated with each technology before blind adoption.

The preoperative computed tomography and magnetic resonance imaging were utilized to create a virtual resection plane and representative 3-dimensional model (3D Systems, Rock Hills, SC). A, Preoperative virtual 3-dimensional model of the sacral-based chondrosarcoma with the associated resection planes and planned postresection defect. B, Virtual representation of 3D-printed resection guides and their intraoperative placement. C, Stereolithographic 3D-printed pelvic model (3D Systems, Rock Hills, SC) made from a photopolymer resin with patient-specific sacral mass, vascular anatomy, and resection planes.

AR-based navigation is helpful in pelvic bone cancer surgery

Can Augmented Reality Be Helpful in Pelvic Bone Cancer Surgery? An In Vitro Study, by Cho et al. CORR (2018), published ahead of print.


Background Application of surgical navigation for pelvic bone cancer surgery may prove useful, but in addition to the fact that research supporting its adoption remains relatively preliminary, the actual navigation devices are physically large, occupying considerable space in already crowded operating rooms. To address this issue, we developed and tested a navigation system for pelvic bone cancer surgery assimilating augmented reality (AR) technology to simplify the system by embedding the navigation software into a tablet personal computer (PC).

Questions/purposes Using simulated tumors and resections in a pig pelvic model, we asked: Can AR-assisted resection reduce errors in terms of planned bone cuts and improve ability to achieve the planned margin around a tumor in pelvic bone cancer surgery?

Methods We developed an AR-based navigation system for pelvic bone tumor surgery, which could be operated on a tablet PC. We created 36 bone tumor models for simulation of tumor resection in pig pelves and assigned 18 each to the AR-assisted resection group and conventional resection group. To simulate a bone tumor, bone cement was inserted into the acetabular dome of the pig pelvis. Tumor resection was simulated in two scenarios. The first was AR-assisted resection by an orthopaedic resident and the second was resection using conventional methods by an orthopaedic oncologist. For both groups, resection was planned with a 1-cm safety margin around the bone cement. Resection margins were evaluated by an independent orthopaedic surgeon who was blinded as to the type of resection. All specimens were sectioned twice: first through a plane parallel to the medial wall of the acetabulum and second through a plane perpendicular to the first. The distance from the resection margin to the bone cement was measured at four different locations for each plane. The largest of the four errors on a plane was adopted for evaluation. Therefore, each specimen had two values of error, which were collected from two perpendicular planes. The resection errors were classified into four grades: ≤ 3 mm; 3 to 6 mm; 6 to 9 mm; and > 9 mm or any tumor violation. Student’s t-test was used for statistical comparison of the mean resection errors of the two groups.

Results The mean of 36 resection errors of 18 pelves in the AR-assisted resection group was 1.59 mm (SD, 4.13 mm; 95% confidence interval [CI], 0.24-2.94 mm) and the mean error of the conventional resection group was 4.55 mm (SD, 9.7 mm; 95% CI, 1.38-7.72 mm; p < 0.001). All specimens in the AR-assisted resection group had errors < 6 mm, whereas 78% (28 of 36) of errors in the conventional group were < 6 mm. Conclusions In this in vitro simulated tumor model, we demonstrated that AR assistance could help to achieve the planned margin. Our model was designed as a proof of concept; although our findings do not justify a clinical trial in humans, they do support continued investigation of this system in a live animal model, which will be our next experiment. Clinical Relevance The AR-based navigation system provides additional information of the tumor extent and may help surgeons during pelvic bone cancer surgery without the need for more complex and cumbersome conventional navigation systems.

Assessment of tumor margins in head and neck cancer using a 3D-navigation system based on PET/CT image-fusion


Assessment of tumor margins in head and neck cancer using a 3D-navigation system based on PET/CT image-fusion – A pilot study, by Zrnc et al. Journal of Cranio-Maxillofacial Surgery (2018).


Determination of tumor margins in patients with squamous cell carcinoma of the head and neck (SCCHN) is mostly based on preoperative magnetic resonance imaging (MRI) or computed tomography scans (CT). Local recurrence of disease is often correlated with the presence of positive resection margins after surgical treatment. Positron emission tomography/computed tomography (PET/CT) imaging plays a crucial role in the assessment of patients with SCCHN. The purpose of this study was to determine whether PET/CT could predict tumor extension.

In 12 patients who underwent surgical treatment of primary SCCHN (Stage III-IV) F18-FDG PET/CT image-fusion was performed on a 3D navigation-system based workstation. Image-guided needle biopsies were obtained from four different, color-coded metabolic areas within the tumor. The histopathological findings were correlated with findings on corresponding PET/CT scans.

81.3% of biopsies from the central area were positive. Specimens taken from the outer metabolic zone were positive in 66.7% of the patients. The highest incidence of positive biopsies was found in the zone adjacent to the outermost area. There was a statistically significant difference in positive tumor histopathology when comparing the various metabolic zones (p = 0.03).

Exact determination of tumor is an important research topic, although results remain controversial. The results of this study suggest that in some cases PET scans may overestimate tumor extension.